200020012002200320042005200620072008
Pages:
«<34567>»
NOTICES: Cellular, Tissue, and Gene Therapies Advisory Committee,
Published: 2007-12-19
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). The meeting will be open to the public.
Name of Committee: Cellular, Tissue and Gene Therapies Advisory Committee.
[[Page 71923]]
General Function of the Committee: To provide advice and
recommendations to the agency on
NOTICES: Psychopharmacologic Drugs Advisory Committee,
Published: 2007-12-19
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). The meeting will be open to the public.
Name of Committee: Psychopharmacologic Drugs Advisory Committee.
General Function of the Committee: To provide advice and recommendations to the agency on FDA's regulatory issues.
NOTICES: Agency information collection activities; proposals, submissions, and approvals,
Published: 2007-12-19
In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction
Act of 1995 concerning opportunity for public comment on proposed
collections of information, the Substance Abuse and Mental Health
Services Administration (SAMHSA) will publish periodic summaries of
proposed projects. To request more information on the proposed projects
or to
NOTICES: FDA Modernization Act of 1997—; Recognized Standards List modifications (Recognition List Number 019),
Published: 2007-12-19
The Food and Drug Administration (FDA) is announcing a
publication containing modifications the agency is making to the list
of standards FDA recognizes for use in premarket reviews (FDA
recognized consensus standards). This publication, entitled
``Modifications to the List of Recognized Standards, Recognition List
Number: 019'' (Recognition List
NOTICES: Agency information collection activities; proposals, submissions, and approvals,
Published: 2007-12-19
Periodically, the Substance Abuse and Mental Health Services
Administration (SAMHSA) will publish a summary of information
collection requests under OMB review, in compliance with the Paperwork
Reduction Act (44 U.S.C. Chapter 35). To request a copy of these
documents, call the SAMHSA Reports Clearance Officer on (240) 2761243.
Project:
NOTICES: Disease, Disability, and Injury Prevention and Control Special Emphasis Panels,
Published: 2007-12-19
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting.
Time and Date: 1 p.m.3 p.m., January 29, 2008 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance with
NOTICES: Disease, Disability, and Injury Prevention and Control Special Emphasis Panels,
Published: 2007-12-19
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting:
Time and Date: 8 a.m.5 p.m., February 8, 2008 (Closed).
Place: Sheraton Gateway Atlanta Airport Hotel, 1900 Sullivan Road, [[Page 71914]]
Atlanta, Georgia
NOTICES: National Center for Health Statistics—; Scientific Counselors Board,
Published: 2007-12-19
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92463), the CDC announces the following meeting of the aforementioned committee:
Times and Dates: 11 a.m.5:30 p.m., January 23, 2008. 8:30 a.m.2 p.m., January 24, 2008.
Place: NCHS Headquarters, 3311 Toledo Road, Hyattsville, Maryland 20782.
Status:
NOTICES: Radiation and Worker Health Advisory Board,
Published: 2007-12-19
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92463), the CDC announces the following meeting of the aforementioned committee and subcommittee:
Subcommittee Meeting Time and Date
10 a.m.12:30 p.m., January 8, 2008
Advisory Board Meeting Times and Dates
1 p.m.4:30 p.m., January 8, 2008
9:30 a.m.5 p.m., January
NOTICES: Medicaid—; State Children's Health Insurance Program; additional allotments to eliminate funding shortfalls,
Published: 2007-12-19
This notice describes the methodology and process we are using
for determining the amounts of certain States' remaining SCHIP funding
shortfalls in Federal fiscal year (FY) 2007, in accordance with the
provisions of the U.S. Troop Readiness, Veteran's Care, Katrina
Recovery, and Iraq Accountability Appropriations Act, 2007. This notice
also
PROPOSED RULES: New safe harbors and special fraud alerts; solicitations,
Published: 2007-12-19
In accordance with section 205 of the Health Insurance
Portability and Accountability Act (HIPAA) of 1996, this annual notice
solicits proposals and recommendations for developing new and modifying
existing safe harbor provisions under the Federal antikickback statute
(section 1128B(b) of the Social Security Act), as well as developing
new OIG
NOTICES: Inventions, Government-owned; availability for licensing,
Published: 2007-12-19
The inventions listed below are owned by an agency of the U.S.
Government and are available for licensing in the U.S. in accordance
with 35 U.S.C. 207 to achieve expeditious commercialization of results
of federallyfunded research and development. Foreign patent
applications are filed on selected inventions to extend market coverage
for companies
NOTICES: Inventions, Government-owned; availability for licensing,
Published: 2007-12-19
The inventions listed below are owned by an agency of the U.S.
Government and are available for licensing in the U.S. in accordance
with 35 U.S.C. 207 to achieve expeditious commercialization of results
of federallyfunded research and development. Foreign patent [[Page 71932]]
applications are filed on selected inventions to extend market coverage
RULES: Vaginal contraceptive and spermicide products (OTC) containing nonoxynol 9; label requirements,
Published: 2007-12-19
The Food and Drug Administration (FDA) is issuing a final
rule establishing new warning statements and other labeling information
for all overthecounter (OTC) vaginal contraceptive drug products
(also known as spermicides, hereinafter referred to as vaginal
contraceptives or vaginal contraceptives/spermicides) containing
nonoxynol 9 (N9). These
RULES: Revisit User Fee Program; Medicare Survey and certification activities,
Published: 2007-12-18
This interim final rule with comment period implements the
continuation of the revisit user fee program for Medicare Survey and
Certification activities, in accordance with the statutory authority in
the Further Continuing Appropriations, 2008 Resolution (``Continuing
Resolution'') budget legislation passed by the Congress and signed by
the
NOTICES: Agency information collection activities; proposals, submissions, and approvals,
Published: 2007-12-17
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 6394766 or send an email
NOTICES: Agency information collection activities; proposals, submissions, and approvals,
Published: 2007-12-17
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 6394766 or send an email
NOTICES: Agency information collection activities; proposals, submissions, and approvals,
Published: 2007-12-17
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
NOTICES: Disease Management Outcomes Measurement,
Published: 2007-12-17
This notice announces the date and location of the Department
of Health and Human Services, Office of the Assistant Secretary for
Planning and Evaluation (HHS/ASPE) Expert Meeting on Disease Management
Outcomes Measurement. The objective of the meeting is to convene a
panel of experts from government, academia, and private industry to
discuss
NOTICES: National Heart, Lung, and Blood Institute,
Published: 2007-12-17
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions
NOTICES: Health information technology: interoperability standards,
Published: 2007-12-17
This notice identifies three (3) additional Consolidated
Health Informatics (CHI) messaging and vocabulary standards
(Multimedia, Allergy, and Disability and Assessments) adopted for use
in Federal government health information technology systems. This work
supplements the work to further the adoption of the first set of 5
standards adopted on
NOTICES: Special Exposure Cohort; employee class designations—; Pantex Plant, TX,
Published: 2007-12-17
The Department of Health and Human Services (HHS) gives notice
as required by 42 CFR 83.12(e) of a decision to evaluate a petition to
designate a class of employees at the Pantex Plant, Amarillo, Texas, to
be included in the Special Exposure Cohort under the Energy Employees
Occupational Illness Compensation Program Act of 2000. The initial
NOTICES: Agency information collection activities; proposals, submissions, and approvals,
Published: 2007-12-17
In compliance with the requirement for the opportunity for public
comment on proposed data collection projects [Section 3506 (c)(2)(A) of
Title 44, United States Code, as amended by the Paperwork Reduction Act
of 1995, Pub. L. 10413], the Health Resources and Services
Administration (HRSA) publishes periodic summaries of proposed projects
NOTICES: Chase Brexton Health Services,
Published: 2007-12-17
HRSA will be providing temporary critical HIV medical care and
treatment services through Chase Brexton Health Services to avoid a
disruption of HIV clinical care to homeless populations in the
Baltimore, Maryland, area.
NOTICES: International Conference on Harmonisation—; Q4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions,
Published: 2007-12-17
The Food and Drug Administration (FDA) is announcing the
availability of a draft guidance entitled ``Q4B Evaluation and
Recommendation of Pharmacopoeial Texts for Use in the ICH Regions;
Annex 3: Test for Particulate Contamination: Subvisible Particles
General Chapter.'' The draft guidance was prepared under the auspices
of the International